Illumina

[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
[video+transcript]Why Alkermes' Depression Drug Stumbled, and How Illumina Plans to Profit From M&A
Motley Fool
Alkermes
depression
ALSK-5461
opioids
Illumina
Pacific Biosciences
Flag link:
Where Will Illumina, Inc. Be in 10 Years?
Where Will Illumina, Inc. Be in 10 Years?
Motley Fool
Illumina
genomic sequencing
Flag link:
Illumina taking out Pacific Biosciences for $1.2B
Illumina taking out Pacific Biosciences for $1.2B
BioCentury
Illumina
Pacific Biosciences
M&A
genomics
Flag link:
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Here's Why Illumina Stock Has Gained 28.3% in 2018 (So Far)
Motley Fool
Illumina
DNA sequencing
NovaSeq
Flag link:
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Here's Why Illumina, Inc. Stock Gained 13.1% in May
Motley Fool
Illumina
gene sequencing
Edico Genome
M&A
Flag link:
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
A Need for Speed: Illumina Acquires San Diego’s Edico Genome
Xconomy
Illumina
Edico Genome
M&A
Flag link:
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Bristol Partners With Illumina On Diagnostic Test To Use With Opdivo
Forbes
Bristol-Myers Squibb
Illumina
DNA sequencing
Opdivo
diagnostics
Flag link:
How biotech firm Illumina smooths out buying for online customers
How biotech firm Illumina smooths out buying for online customers
Digital Commerce 360
Illumina
genomics
e-commerce
Flag link:
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
5 Reasons Illumina Enjoyed a Big J.P. Morgan Conference Bounce
Motley Fool
Illumina
JPMHC 2018
NovaSeq
iSeq
Thermofisher
gene sequencing
Flag link:
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Illumina Unveils $20,000 Desktop Sequencer Aimed At Sequencing Germs
Forbes
Illumina
DNA sequencing
iSeq
JPMHC 2018
Flag link:
Disruptor Alert: These 5 Companies Are Changing Healthcare
Disruptor Alert: These 5 Companies Are Changing Healthcare
Motley Fool
CRISPR Therapeutics
Editas Medicine
Illumina
IBM
Intellia Therapeutics
gene editing
gene sequencing
artificial intelligence
Flag link:
3 Things to Expect in Illumina's Q3 Earnings Results
3 Things to Expect in Illumina's Q3 Earnings Results
Motley Fool
Illumina
earnings
Flag link:
10 Reasons Illumina's Momentum Is Just Cranking Up
10 Reasons Illumina's Momentum Is Just Cranking Up
Motley Fool
Illumina
NovaSeq
HiSeq
China
Helix
Flag link:
3 Top Gene-Sequencing Stocks Poised for Solid Growth
3 Top Gene-Sequencing Stocks Poised for Solid Growth
Motley Fool
gene sequencing
Thermo Fisher
Illumina
Qiagen
Flag link:
3 Things to Look for in Illumina's Q1 Results
3 Things to Look for in Illumina's Q1 Results
Motley Fool
Illumina
earnings
Flag link:
What to Expect When Illumina Reports Earnings
What to Expect When Illumina Reports Earnings
Motley Fool
Illumina
earnings
Flag link:
Did Roche Just Hand Illumina Pacific Biosciences’ Head on a Platter?
Did Roche Just Hand Illumina Pacific Biosciences’ Head on a Platter?
Motley Fool
Roche
Illumina
Pacific Biosciences
diagnostics
Flag link:
How Illumina Plans to Change Medicine Forever
How Illumina Plans to Change Medicine Forever
Motley Fool
Illumina
personalized medicine
gene sequencing
JPMHC 2017
Flag link:
Biotech Investing: 3 Bold Predictions for 2017
Biotech Investing: 3 Bold Predictions for 2017
Motley Fool
biotech
Incyte
Biogen
Biomarin
Gilead Sciences
Illumina
Flag link:
Can Illumina Regain Its Mojo?
Can Illumina Regain Its Mojo?
Motley Fool
Illumina
DNA sequencing
Flag link:

Pages